Earnings

Earnings Articles

Some of its issues may be seasonal, but the reality is that Blue Apron has become an eyesore to its investors.
The death of the U.S. Postal Service has been written about for years, and at least partially exaggerated. However, its new earnings report shows that it is marching in the wrong direction.
Most people who follow Macy's agree that its earnings were good enough to suggest that it can survive, at least short term. However, its forecast brought doubt about its future.
Macy's reported quarterly results this morning that beat both profit and revenue estimates. But full-year guidance is below estimates and the company's shrinking footprint is troubling to investors.
Office Depot shares were crushed following its quarterly results, but how low do they have to sink before some other company is willing to step in and buy it out?
Food prep and delivery service provider Blue Apron has been under fire since it first came public, but a positive showing from its earnings report could alleviate some of the concerns.
On Thursday, Kohl’s, Macy’s and Nordstrom are all on the docket to report, and 24/7 Wall St. has put together a brief preview on each of these major retailers.
Shares of Priceline and TripAdvisor are getting pounded this morning following earnings reports that were mixed. But the big issue is future growth.
Office Depot reported disappointing second-quarter financial results before the markets opened on Wednesday.
Mylan released its most recent quarterly earnings report before the markets opened on Wednesday. Unfortunately, the earnings and guidance weren't strong enough to hold up the firm and as a result...
3D printing company Stratasys beat profit and revenue estimates and reiterated prior guidance for full-year results.
Walt Disney Co. (NYSE: DIS) reported its most recent earnings results after the markets closed on Tuesday. The Mouse House said that it had $1.58 in earnings per share (EPS) and $14.23 billion in...
Disney is scheduled to release its fiscal third-quarter financial results after the markets close on Tuesday.
Valeant Pharmaceuticals reported mixed second-quarter financial results before the markets opened on Tuesday.
When FibroGen released its most recent quarterly results after the markets closed on Monday, its was not the most important news that broke.